Flynn C, Chang D
Diagnostics (Basel). 2024; 14(11).
PMID: 38893627
PMC: 11172335.
DOI: 10.3390/diagnostics14111100.
Peng X, Lu X, Yang D, Liu J, Wu H, Peng H
Medicine (Baltimore). 2024; 103(11):e37496.
PMID: 38489709
PMC: 10939595.
DOI: 10.1097/MD.0000000000037496.
Schardey J, Lu C, Neumann J, Wirth U, Li Q, Jiang T
Cancers (Basel). 2023; 15(19).
PMID: 37835436
PMC: 10571767.
DOI: 10.3390/cancers15194743.
Yoo J, Jo S, Shin D, Park J, Kim S, Lim H
Diagnostics (Basel). 2023; 13(18).
PMID: 37761270
PMC: 10529363.
DOI: 10.3390/diagnostics13182904.
Ning R, Pan S, Xiao D, Zheng Y, Zhang J
Am J Cancer Res. 2023; 13(5):1845-1862.
PMID: 37293146
PMC: 10244099.
A new prediction model of hepatocellular carcinoma based on N7-methylguanosine modification.
Yang L, Wang Y, Mou Z, Xiong P, Deng K, Wen J
BMC Gastroenterol. 2023; 23(1):131.
PMID: 37081394
PMC: 10120187.
DOI: 10.1186/s12876-023-02757-9.
Multiplexed molecular imaging with surface enhanced resonance Raman scattering nanoprobes reveals immunotherapy response in mice multichannel image segmentation.
Andreou C, Plakas K, Berisha N, Gigoux M, Rosch L, Mirsafavi R
Nanoscale Horiz. 2022; 7(12):1540-1552.
PMID: 36285605
PMC: 10360075.
DOI: 10.1039/d2nh00331g.
Influence of Androgen Deprivation Therapy on the PD-L1 Expression and Immune Activity in Prostate Cancer Tissue.
Sommer U, Ebersbach C, Beier A, Baretton G, Thomas C, Borkowetz A
Front Mol Biosci. 2022; 9:878353.
PMID: 35836932
PMC: 9273856.
DOI: 10.3389/fmolb.2022.878353.
Construction of a Novel Immune-Related mRNA Signature to Predict the Prognosis and Immune Characteristics of Human Colorectal Cancer.
Li J, Han T, Wang X, Wang Y, Chen X, Chen W
Front Genet. 2022; 13:851373.
PMID: 35401707
PMC: 8984163.
DOI: 10.3389/fgene.2022.851373.
A nomogram-based immunoprofile predicts clinical outcomes for stage II and III human colorectal cancer.
Wang L, Chang N, Wu L, Li J, Zhang L, Chen Y
Mol Clin Oncol. 2021; 15(6):257.
PMID: 34712487
PMC: 8549000.
DOI: 10.3892/mco.2021.2419.
Analysis of Immune Landscape Reveals Prognostic Significance of Cytotoxic CD4 T Cells in the Central Region of pMMR CRC.
Qi J, Liu X, Yan P, He S, Lin Y, Huang Z
Front Oncol. 2021; 11:724232.
PMID: 34631551
PMC: 8493090.
DOI: 10.3389/fonc.2021.724232.
Immunoprofiling: An Encouraging Method for Predictive Factors Examination in Lung Cancer Patients Treated with Immunotherapy.
Wojas-Krawczyk K, Pasnik I, Kucharczyk T, Wieleba I, Krzyzanowska N, Gil M
Int J Mol Sci. 2021; 22(17).
PMID: 34502043
PMC: 8431454.
DOI: 10.3390/ijms22179133.
Multiplex Immunofluorescence Tyramide Signal Amplification for Immune Cell Profiling of Paraffin-Embedded Tumor Tissues.
Hernandez S, Rojas F, Laberiano C, Lazcano R, Wistuba I, Parra E
Front Mol Biosci. 2021; 8:667067.
PMID: 33996912
PMC: 8118604.
DOI: 10.3389/fmolb.2021.667067.
Identification of an Immune Gene Signature Based on Tumor Microenvironment Characteristics in Colon Adenocarcinoma.
Chen Y, Zhao J
Cell Transplant. 2021; 30:9636897211001314.
PMID: 33787354
PMC: 8020110.
DOI: 10.1177/09636897211001314.
Immunoprofiling in Neuroendocrine Neoplasms Unveil Immunosuppressive Microenvironment.
Busse A, Mochmann L, Spenke C, Arsenic R, Briest F, Johrens K
Cancers (Basel). 2020; 12(11).
PMID: 33228231
PMC: 7699546.
DOI: 10.3390/cancers12113448.
Immune contexture analysis in immuno-oncology: applications and challenges of multiplex fluorescent immunohistochemistry.
Shakya R, Nguyen T, Waterhouse N, Khanna R
Clin Transl Immunology. 2020; 9(10):e1183.
PMID: 33072322
PMC: 7541822.
DOI: 10.1002/cti2.1183.
Cytotoxic CD8 T cells in cancer and cancer immunotherapy.
Raskov H, Orhan A, Christensen J, Gogenur I
Br J Cancer. 2020; 124(2):359-367.
PMID: 32929195
PMC: 7853123.
DOI: 10.1038/s41416-020-01048-4.
Understanding genomics and the immune environment of penile cancer to improve therapy.
Aydin A, Chahoud J, Adashek J, Azizi M, Magliocco A, Ross J
Nat Rev Urol. 2020; 17(10):555-570.
PMID: 32812000
DOI: 10.1038/s41585-020-0359-z.
Immune profiling of pediatric solid tumors.
Terry R, Meyran D, Ziegler D, Haber M, Ekert P, Trapani J
J Clin Invest. 2020; 130(7):3391-3402.
PMID: 32538896
PMC: 7324195.
DOI: 10.1172/JCI137181.
Offsetting Expression Profiles of Prognostic Markers in Prostate Tumor vs. Its Microenvironment.
Jia Z, Zhu J, Zhuo Y, Li R, Qu H, Wang S
Front Oncol. 2019; 9:539.
PMID: 31316912
PMC: 6611437.
DOI: 10.3389/fonc.2019.00539.